Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Volume 16 Issue 9, September 2020

The September issue includes Reviews on placental development, exercise adaptations, methods to generate functional β-cells and epigenetic factors that affect reproductive function, as well as two Comment articles on fragility fractures and obesity during the COVID-19 pandemic.

Image: Dermal adipocyte staining in the skin of a 35-day-old ‘adipochaser’ mouse. Image supplied by Zhuzhen Zhang and Philipp Scherer, Touchstone Diabetes Center, The University of Texas Southwestern Medical Center, USA. Cover design: Jennie Vallis.

Comment

  • The COVID-19 pandemic has broad implications for the care of patients with bone fragility. A dramatic surge in fractures and related mortality is expected in the next few months. We pledge to intensify the current efforts to improve the management of bone health, and to prioritize fragility fracture care and prevention.

    • Nicola Napoli
    • Ann L. Elderkin
    • Sundeep Khosla
    Comment

    Advertisement

  • The sudden outbreak and global spread of COVID-19 represents one of the most profound societal and public health challenges in modern times. In this Comment, we call attention to the possibility that the societal strategies implemented to oppose COVID-19 might have long-term, negative effects on the obesity epidemic.

    • Christoffer Clemmensen
    • Michael Bang Petersen
    • Thorkild I. A. Sørensen
    Comment
Top of page ⤴

Research Highlights

Top of page ⤴

News & Views

  • Thermogenic adipose tissue is a metabolic sink for excess fuel and is a promising target for the treatment of obesity and type 2 diabetes mellitus. However, hurdles exist in activating thermogenic adipose tissue in humans. A new study developed a drug screening platform utilizing human beige adipose tissue and identified non-canonical activators.

    • Anthony R. P. Verkerke
    • Shingo Kajimura
    News & Views
  • For type 1 diabetes mellitus (T1DM), keeping glucose levels within the normal range of 65–150 mg/dl with administered insulin has had limited success. Now, Fussenegger and colleagues have engineered cells to release insulin in response to electrical signals, but can this advance lead to better glucose control?

    • Gordon C. Weir
    News & Views
Top of page ⤴

Reviews

Top of page ⤴

Search

Quick links